Accuracy Assessment of an Automatic Blood Pressure Measurement Device in Adult Volunteers

Sponsor
William Marsh Rice University (Other)
Overall Status
Completed
CT.gov ID
NCT02267577
Collaborator
(none)
90
1
1
33.3
2.7

Study Details

Study Description

Brief Summary

The research team has developed an automatic blood pressure monitor (Sphygmo) to be used for the monitoring and diagnosis of pre-eclampsia in pregnant women, particularly in low-resource settings where current monitoring is limited.

90 adult volunteers will be enrolled by researchers at Rice University. The participant will be seated in a comfortable chair with arm at heart level. Arm circumference will be measured and a blood pressure cuff will be placed on the arm. The cuff will be inflated and blood pressure measurements will be taken by a commercially available device and by the Sphygmo device. Blood pressure measurements from both devices will be recorded. The participant's blood pressure will be measured up to 9 times with a waiting period of 45-60 seconds between each measurement.

The results of this study will be used to optimize the blood pressure detection algorithm and thus further develop the device.

Condition or Disease Intervention/Treatment Phase
  • Device: Sphygmo: Automatic Blood Pressure Monitor
  • Device: GE Dinamap ProCare Automatic Blood Pressure Monitor
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
90 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Participants enrolled in the study will have their blood pressure measured multiple times with both the GE Dinamap Procare commercial blood pressure monitor and Sphygmo, the experimental blood pressure monitoring device.Participants enrolled in the study will have their blood pressure measured multiple times with both the GE Dinamap Procare commercial blood pressure monitor and Sphygmo, the experimental blood pressure monitoring device.
Masking:
None (Open Label)
Primary Purpose:
Device Feasibility
Official Title:
Accuracy Assessment of an Automatic Blood Pressure Measurement Device in Adult Volunteers
Study Start Date :
Jan 1, 2015
Actual Primary Completion Date :
Oct 1, 2015
Actual Study Completion Date :
Oct 12, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Healthy Adults Volunteers

Men and women over the age of 18 will have their blood pressure measured with both the Sphygmo: Automatic Blood Pressure Monitor device and the GE Dinamap ProCare automatic blood pressure monitor.

Device: Sphygmo: Automatic Blood Pressure Monitor
A team of engineers from Rice University has recently developed Sphygmo, an ambulatory, low-cost blood pressure monitor for use in the diagnosis and management of pre-eclampsia in low-resource hospitals.

Device: GE Dinamap ProCare Automatic Blood Pressure Monitor
This commercially available gold standard blood pressure monitor will be used as a control to assess the accuracy of the Sphygmo device.

Outcome Measures

Primary Outcome Measures

  1. Accuracy of Blood Pressure Measurement by Sphygmo Relative to the Clinical Standard. [Blood pressure was measured an average of 9 times for each participant during their single visit and the mean of these measurements was recorded and used for analysis. The measurement period lasted approximately 30-45 minutes.]

    Mean difference of systolic and diastolic blood pressure readings between Sphygmo device and the gold standard sphygmomanometer.

  2. Percentage of Sphygmo Readings That Were With < 5 mmHg, < 10 mmHg, and < 15 mmHg of the Readings by the Gold Standard Sphygmomanometer. [Blood pressure was measured an average of 9 times for each participant during their single visit and the mean of these measurements was recorded and used for analysis. The measurement period lasted approximately 30-45 minutes.]

    The British Hypertension society defines a specific criteria for the accuracy of a sphygmomanometer. Devices are graded according to the cumulative percentage of readings that have an absolute difference between the more favorable observer's mercury sphygmomanometer readings and the test device of < 5 mmHg, < 10 mmHg, and < 15 mmHg. A letter grade of "A" requires that over 60%, 85%, and 95% were achieved in the < 5 mmHg, < 10 mmHg, and <15 mmHg categories, respectively. A letter grade of "B" requires that over 50%, 75%, and 90% were achieved in the < 5 mmHg, < 10 mmHg, and <15 mmHg categories, respectively. The test device achieved a grade of (B/B) with the validation data from this study.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 18 years of age or older

  • Willing and able to provide informed consent

Exclusion Criteria:
  • Unable to provide informed consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Rice University Houston Texas United States 77030

Sponsors and Collaborators

  • William Marsh Rice University

Investigators

  • Principal Investigator: Rebecca R Kortum, PhD, William Marsh Rice University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Rebecca Richards-Kortum, Stanley C. Moore Professor of Bioengineering, William Marsh Rice University
ClinicalTrials.gov Identifier:
NCT02267577
Other Study ID Numbers:
  • 14-082F-A
  • 51262
First Posted:
Oct 17, 2014
Last Update Posted:
Mar 6, 2020
Last Verified:
Mar 1, 2020
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title Healthy Adult Volunteers
Arm/Group Description Men and women over the age of 18 who will have their blood pressure measured using both the experimental blood pressure monitor (Sphygmo), and the gold-standard, commercial blood pressure monitor (GE Dinamap ProCare).
Period Title: Overall Study
STARTED 85
COMPLETED 81
NOT COMPLETED 4

Baseline Characteristics

Arm/Group Title Adults Volunteers
Arm/Group Description Men and women over the age of 18 Sphygmo: Automatic Blood Pressure Monitor: A team of engineers from Rice University has recently developed Sphygmo, an ambulatory, low-cost blood pressure monitor for use in the diagnosis and management of pre-eclampsia in low-resource hospitals.
Overall Participants 85
Age (years) [Median (Full Range) ]
Median (Full Range) [years]
50
Sex: Female, Male (Count of Participants)
Female
65
76.5%
Male
20
23.5%
Region of Enrollment (participants) [Number]
United States
85
100%

Outcome Measures

1. Primary Outcome
Title Accuracy of Blood Pressure Measurement by Sphygmo Relative to the Clinical Standard.
Description Mean difference of systolic and diastolic blood pressure readings between Sphygmo device and the gold standard sphygmomanometer.
Time Frame Blood pressure was measured an average of 9 times for each participant during their single visit and the mean of these measurements was recorded and used for analysis. The measurement period lasted approximately 30-45 minutes.

Outcome Measure Data

Analysis Population Description
Data from nine participants of the original 81 who completed the study was excluded on account of the observer reporting a difficulty in hearing, movement, or uncertainty with the measurement.
Arm/Group Title Healthy Adult Volunteers
Arm/Group Description Men and women over the age of 18 who had their blood pressure measured using both the experimental device (Sphygmo) as well as the commercial, gold-standard monitor (GE Dinamap ProCare).
Measure Participants 72
Mean Systolic BP - Sphygmo
122.5
(14.9)
Mean Diastolic BP Difference - Sphygmo
74.5
(11.1)
Mean Systolic BP - GE Dinamap
123.1
(17.7)
Mean Diastolic BP - GE Dinamap
72.1
(12.6)
2. Primary Outcome
Title Percentage of Sphygmo Readings That Were With < 5 mmHg, < 10 mmHg, and < 15 mmHg of the Readings by the Gold Standard Sphygmomanometer.
Description The British Hypertension society defines a specific criteria for the accuracy of a sphygmomanometer. Devices are graded according to the cumulative percentage of readings that have an absolute difference between the more favorable observer's mercury sphygmomanometer readings and the test device of < 5 mmHg, < 10 mmHg, and < 15 mmHg. A letter grade of "A" requires that over 60%, 85%, and 95% were achieved in the < 5 mmHg, < 10 mmHg, and <15 mmHg categories, respectively. A letter grade of "B" requires that over 50%, 75%, and 90% were achieved in the < 5 mmHg, < 10 mmHg, and <15 mmHg categories, respectively. The test device achieved a grade of (B/B) with the validation data from this study.
Time Frame Blood pressure was measured an average of 9 times for each participant during their single visit and the mean of these measurements was recorded and used for analysis. The measurement period lasted approximately 30-45 minutes.

Outcome Measure Data

Analysis Population Description
Data from nine participants of the original 81 who completed the study was excluded on account of the observer reporting a difficulty in hearing, movement, or uncertainty with the measurement.
Arm/Group Title Adults Volunteers
Arm/Group Description Men and women over the age of 18 who will have their blood pressure measured using both the experimental blood pressure monitor (Sphygmo), and the gold-standard, commercial blood pressure monitor (GE Dinamap ProCare).
Measure Participants 72
Systolic Difference <5 mmHg
56
Systolic Difference <10 mmHg
79
Systolic Difference <15 mmHg
92
Diastolic Difference <5 mmHg
53
Diastolic Difference <10 mmHg
77
Diastolic Difference <15 mmHg
90

Adverse Events

Time Frame
Adverse Event Reporting Description
Arm/Group Title Adults Volunteers
Arm/Group Description Men and women over the age of 18 Sphygmo: Automatic Blood Pressure Monitor: A team of engineers from Rice University has recently developed Sphygmo, an ambulatory, low-cost blood pressure monitor for use in the diagnosis and management of pre-eclampsia in low-resource hospitals.
All Cause Mortality
Adults Volunteers
Affected / at Risk (%) # Events
Total / (NaN)
Serious Adverse Events
Adults Volunteers
Affected / at Risk (%) # Events
Total 1/85 (1.2%)
Cardiac disorders
High Blood Pressure 1/85 (1.2%) 1
Other (Not Including Serious) Adverse Events
Adults Volunteers
Affected / at Risk (%) # Events
Total 0/85 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Dr. Rebecca Richards-Kortum
Organization Rice 360: Institute for Global Health
Phone 713-348-3823
Email rkortum@rice.edu
Responsible Party:
Rebecca Richards-Kortum, Stanley C. Moore Professor of Bioengineering, William Marsh Rice University
ClinicalTrials.gov Identifier:
NCT02267577
Other Study ID Numbers:
  • 14-082F-A
  • 51262
First Posted:
Oct 17, 2014
Last Update Posted:
Mar 6, 2020
Last Verified:
Mar 1, 2020